Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Next-Generation Sequencing-Based Molecular Profiling Using Cell-Free DNA: A Valuable Tool for the Diagnostic and Prognostic Evaluation of Patients With Gastric Cancer

  • Mi-Ae Jang (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Published : 2024.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. International Agency for Research on Cancer, WHO. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer, https://gco.iarc.fr/today/data/factsheets/cancers/39-Allcancers-fact-sheet.pdf (Updated on Sep 2023).
  2. National Comprehensive Cancer Network. Gastric Cancer: National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Version 2.2023. August 29, 2023.
  3. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet 2020;396:635-48. https://doi.org/10.1016/S0140-6736(20)31288-5
  4. Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2022;33:1005-20. https://doi.org/10.1016/j.annonc.2022.07.004
  5. Pietrantonio F, Miceli R, Raimondi A, Kim YW, Kang WK, Langley RE, et al. Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer. J Clin Oncol 2019;37:3392-400. https://doi.org/10.1200/JCO.19.01124
  6. Telekes A and Horváth A. The role of cell-free DNA in cancer treatment decision making. Cancers (Basel) 2022;14:6115. https://doi.org/10.3390/cancers14246115
  7. Zhong Y, Xu F, Wu J, Schubert J, Li MM. Application of next generation sequencing in laboratory medicine. Ann Lab Med 2021;41:25-43. https://doi.org/10.3343/alm.2021.41.1.25
  8. Huffman BM, Aushev VN, Budde GL, Chao J, Dayyani F, Hanna D, et al. Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers. JCO Precis Oncol 2022;6:e2200420. https://doi.org/10.1200/PO.22.00420
  9. Grizzi G, Salati M, Bonomi M, Ratti M, Holladay L, De Grandis MC, et al. Circulating tumor DNA in gastric adenocarcinoma: future clinical applications and perspectives. Int J Mol Sci 2023;24:9421. https://doi.org/10.3390/ijms24119421
  10. Lengyel CG, Hussain S, Trapani D, El Bairi K, Altuna SC, Seeber A, et al. The emerging role of liquid biopsy in gastric cancer. J Clin Med 2021;10. https://doi.org/10.3390/jcm10102108
  11. Kim B, Kim Y, Cho J, Lee K. Identification of potential genomic alterations using pan-cancer cell-free DNA next-generation sequencing in patients with gastric cancer. Ann Lab Med 2023;44:164-73. https://doi.org/10.3343/alm.2023.0187
  12. Cho SM, Lee HS, Jeon S, Kim Y, Kong SY, Lee JK, et al. Cost-effectiveness analysis of three diagnostic strategies for the detection of EGFR mutation in advanced non-small cell lung cancer. Ann Lab Med 2023;43:605-13. https://doi.org/10.3343/alm.2023.43.6.605
  13. Shin S, Woo HI, Kim JW, MD YK, Lee KA. Clinical practice guidelines for pre-analytical procedures of plasma epidermal growth factor receptor variant testing. Ann Lab Med 2022;42:141-9. https://doi.org/10.3343/alm.2022.42.2.141